AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Proposed listing date: 28 SEPTEMBER 2017
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| VG1 | Ann: Update - Notification of buy-back - VG1 | 04/02/25 | 0 | 1 | |||
|
|||||||
| VG1 | Ann: February 2018 NTA | 19/04/18 | 4 | 534 | |||
|
|||||||
| VG1 | Ann: Change of Director's Interest Notice - Noel Whittaker | 13/04/18 | 0 | 76 | |||
|
|||||||
| VG1 | Ann: Change of Director's Interest Notice - Douglas Tynan | 13/04/18 | 0 | 57 | |||
|
|||||||
| VG1 | Ann: Change of Director's Interest Notice - Robert Luciano | 13/04/18 | 0 | 57 | |||
|
|||||||
| VG1 | Ann: March 2018 NTA | 09/04/18 | 0 | 78 | |||
|
|||||||
| VG1 | Ann: Change of Director's Interest Notice - Robert Luciano | 14/03/18 | 0 | 127 | |||
|
|||||||
See All Discussions
ASX News